BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7488321)

  • 21. PPADS inhibits P2Y1 purinoceptors in rat brain capillary endothelial cells and in rat ileal myocytes by an indirect mechanism.
    Vigne P; Pacaud P; Loirand G; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1998 Mar; 244(2):332-5. PubMed ID: 9514922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
    Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
    Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple motor effects of ATP and their inhibition by P purinoceptor antagonist, pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid in the small intestine of the guinea-pig.
    Barthó L; Undi S; Benkó R; Wolf M; Lázár Z; Lénárd L; Maggi CA
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):488-95. PubMed ID: 16635108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lidocaine, codeine and vadocaine hydrochloride on platelet aggregation in human platelet-rich plasma.
    Kangasaho M
    Arzneimittelforschung; 1988 Apr; 38(4A):613-6. PubMed ID: 2840087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High sodium intake increases platelet aggregation in normal females.
    Gow IF; Padfield PL; Reid M; Stewart SE; Edwards CR; Williams BC
    J Hypertens Suppl; 1987 Dec; 5(5):S243-6. PubMed ID: 3481816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
    Léon C; Hechler B; Vial C; Leray C; Cazenave JP; Gachet C
    FEBS Lett; 1997 Feb; 403(1):26-30. PubMed ID: 9038354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the development of allodynia by intrathecally administered P2 purinoceptor agonists and antagonists in mice.
    Fukuhara N; Imai Y; Sakakibara A; Morita K; Kitayama S; Tanne K; Dohi T
    Neurosci Lett; 2000 Sep; 292(1):25-8. PubMed ID: 10996441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka.
    Li JZ; Lian EC
    Thromb Haemost; 1988 Jun; 59(3):435-9. PubMed ID: 2973150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orphanin FQ causes contractions via inhibiting purinergic pathway in the rat colon.
    Takahashi T; Bagnol D; Schneider D; Mizuta Y; Ishiguchi T; LePard K; Galligan JJ; Watson SJ; Owyang C
    Gastroenterology; 2000 Oct; 119(4):1054-63. PubMed ID: 11040192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of new 1,3,4-thiadiazines on platelet aggregation in vitro and ex vivo].
    Logvinova OS; Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
    Eksp Klin Farmakol; 2010 Aug; 73(8):21-5. PubMed ID: 20919553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role for purinergic receptors in memory processing in young chicks.
    Cronin C; Edwards TM; Gibbs ME
    Behav Brain Res; 2011 Oct; 223(2):417-20. PubMed ID: 21600243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of divalent cations on the interaction of platelets with tumor cells: aggregation and perfusion studies with two homologous human systems.
    Bastida E; Escolar G; Ordinas A; Giardina SL; Jamieson GA
    J Lab Clin Med; 1985 Jul; 106(1):68-74. PubMed ID: 4009024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of adrenergic blockers on platelet aggregation.
    Orts A; Martí JL; Marco J; Baltar I; Castejón J
    Rev Esp Fisiol; 1979 Sep; 35(3):269-72. PubMed ID: 41294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of P2-purinoceptor antagonists on hemolysate-induced and adenosine 5'-triphosphate-induced contractions of dog basilar artery in vitro.
    Sima B; Macdonald L; Marton LS; Weir B; Zhang J
    Neurosurgery; 1996 Oct; 39(4):815-21; discussion 821-2. PubMed ID: 8880777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise?
    Buckwalter JB; Taylor JC; Hamann JJ; Clifford PS
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H633-9. PubMed ID: 14551053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of carbenicillin and phosphomycin on ADP induced platelet aggregation.
    Orts A; Martí JL; Castejón J; Baltar I; Esplugues J
    Rev Esp Fisiol; 1979 Sep; 35(3):265-8. PubMed ID: 504765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.
    Lambrecht G; Friebe T; Grimm U; Windscheif U; Bungardt E; Hildebrandt C; Bäumert HG; Spatz-Kümbel G; Mutschler E
    Eur J Pharmacol; 1992 Jul; 217(2-3):217-9. PubMed ID: 1330591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA; Hourani SM
    Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro study of the possible interaction between human platelets and cephalosporins.
    Cazzola M; Santangelo G; Martucci P; Caputi M
    Int J Clin Pharmacol Res; 1991; 11(1):7-10. PubMed ID: 1874581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P2-purinergic receptor antagonists reduce the minimum alveolar concentration of inhaled volatile anesthetics.
    Masaki E; Ebisawa T; Kondo I; Hayashida K; Matsumoto Y; Kawamura M
    Brain Res; 2000 May; 864(1):130-3. PubMed ID: 10793195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.